Search Results
OutSmarting Osteosarcoma Panel at FACTOR 2023
MIB Agents Programs Panel at FACTOR 2023
Comparative Oncology Panel at FACTOR 2023
FACTOR 2023 Highlights
The OutSmarting Osteosarcoma Research Grant Program
Osteosarcoma Update from Dr. Huang - 2019 OutSmarting Osteosarcoma recipient
Focal Adhesion Kinase Inhibition to Improve Losartan-Sunitinib Immunotherapy in Metastatic Osteo
The Importance of Patient-Powered Osteosarcoma Research: Count Me In
MIB Agents and SARC: A Case Study in Collaboration
Osteosarcoma OBites: Sauer, PhD "Preventing OS Lethal Recurrence-Targeting Disseminated Tumor Cells”
Overcoming PD-1 Inhibitor Resistance in Metastatic Osteosarcoma
Reprogramming NK Cells Within the Tumor Microenvironment of Osteosarcoma Lung Metastases
